Podcasts about neuropsychiatric symptoms

Dr. Medeya Tsnobiladze's Background A naturopathic doctor specializing in neurodegenerative conditions and chronic infections. Extensive experience treating Lyme disease in her Connecticut-based practice. Rising Lyme Disease Cases in Connecticut Observations of increasing prevalence in patients. Impact of delayed diagnosis on long-term health outcomes. Neurodegenerative Links to Lyme Disease Connection between Lyme disease and conditions like Alzheimer's. Emerging research on Borrelia's role in amyloid plaque formation in the brain. Neuropsychiatric Symptoms of Lyme & Co-infections Differences in brain and nervous system symptoms between Borrelia and Bartonella infections. The need for individualized treatment approaches based on symptom presentation. Comprehensive Testing for Lyme & Co-infections Importance of using specialty labs for accurate diagnosis. The role of advanced testing in identifying persistent infections. Cardiovascular Complications of Lyme Disease Manifestations such as arrhythmias, myocarditis, and dilated cardiomyopathy. Reversibility of some Lyme-related heart conditions with appropriate antimicrobial treatment. Integrative & Collaborative Treatment Approaches How Dr. Tsnobiladze's naturopathic clinic works alongside conventional medicine. Holistic therapies to support neurological and cardiovascular recovery. Resources & Links: Follow the latest ILADS updates at ILADS.org Learn more about Dr. Medeya Tsnobiladze and Fairfield Family Health: FairfieldFamilyHealth.com Stay connected with Tick Boot Camp: Website | Instagram | Facebook | YouTube | TikTok | Twitter (X)

This interview is part of our neurological Long COVID section of the series. Professor Thida Thant MD is an award-winning consultation liaison psychiatrist and Director of the Psychiatric Consultation for the Medically Complex Clinic at the University of Colorado, where she provides rehabilitation for Long COVID survivors. She is one of the few psychiatrists we have found who is taking a lead in the rehabilitation of people with complex chronic disease.References1 Psychiatric Consultation for the Medically Complex Program at the University of Colorado2 APA Resource Document on Neuropsychiatric Symptoms of Subacute & Chronic Long COVID

In this fascinating episode recorded at #BSR24, Dr Melanie Sloan joins Prof Ernest Choy to discuss the latest results from the INSPIRE study, which seeks to understand neuropsychiatric symptom prevalence and impact in people with systemic autoimmune rheumatic diseases (SARDs). Dr Melanie Sloan is a researcher in the Department of Public Health and Primary Care at the University of Cambridge. Her research focuses on improving patient-clinician relationships, as well as trialling interventions for patients with SARDs.  Want to find out more about Melanie's research? Here's your further reading list: Prevalence and identification of neuropsychiatric symptoms in SARDs Neuropsychiatric symptoms in lupusAttribution of neuropsychiatric symptoms and prioritisation of evidence in lupusProdromal neuropsychiatric symptoms in lupusKeywords: autoimmune diseases, lupus, rheumatology, nightmares, daymares, mental health, psychosis, communication. Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

Join us for part 2 of BrainStorm's interview with Dr. Pierre Tariot, former Director for Banner Alzheimer's Institute and Co-Director of The International Alzheimer's Prevention Project. Host Meryl Comer asks Dr. Tariot, who has devoted his career to the care and study of people with or at risk for Alzheimer's disease, about the neuropsychiatric features of dementia. Dr. Tariot highlights the advancements in understanding and treating these behaviors associated with Alzheimer's.  You won't want to miss this episode. This episode is sponsored by Otsuka and Lundbeck.Support the show

Which common infection is associated with frailty in older adults? Find out about this and more in today's PV Roundup podcast.

Are you familiar with the symptoms of Alzheimer's? Neuropsychiatric symptoms, or NPS, are mood and emotional symptoms of dementias and other brain diseases that are often overlooked and under-treated. This Alzheimer's Awareness Month, we're amplifying the voices of those experiencing NPS. Today, we're joined by Terry Montgomery, a friend of the alliance, a patient advocate, and someone who, after receiving a dementia diagnosis, has committed her voice to ensuring that Alzheimer's patients have access to treatments and care and that there's a nurturing community for everyone.

This episode features an interview with Ram Mukunda and Claudia Grimaldi from IGC Pharma, a clinical-stage pharmaceutical company focused on improving the health and well-being of patients affected by Alzheimer's disease and bringing therapies for it to market. The company is currently conducting a Phase II study with IGC-AD1, an investigational low-dose tetrahydrocannabinol-(THC) based formulation that reduces neuropsychiatric symptoms such as agitation in dementia due to Alzheimer's. The drug is the only natural THC-based investigational drug undergoing FDA trials. Ram and Claudia spoke about the compound, including clinical data from the ongoing trials evaluating it.Ram Mukunda is the founder and CEO of IGC Pharma. Previously, he served as Chairman and CEO of Startec Global Communications Corp., Council Member at Harvard Kennedy School of Government and Council Member at Belfer Center for Science & International Affairs. Ram Mukunda has an undergraduate and a graduate degree in biomedical engineering from the University of Maryland.Claudia Grimaldi is currently Vice President, Principal Finance Officer, and Chief Compliance Officer at IGC. She has been with the company for almost 12 years with increasing responsibilities including managing SEC and NYSE filings, regulatory compliance and disclosures. She is also the Managing Director of IGC Pharma Columbia, a director of the company's subsidiary in India and a director of the board at IGC. Ms. Grimaldi is a psychologist by training, is certified as a public director by the NACD and has an MBA from Meredith College in North Carolina.Tune into this episode to hear from the team at IGC about the company's commitment to discovering new treatments for Alzheimer's to help improve the lives of patients and their caregivers.For more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

✨ This episode will change the way you see science, your connection with God, and absolutely BLOW your mind with the immense power God created within you to heal and restore your soul. For God to do the supernatural though, you must consistently do three key things to restore your soul. In this episode, Restoration of the Soul Part 1: The Science of the Soul, I review with you what those three things are, the numerous scientific research studies that back them up, and discuss how implementing these easy things consistently into your daily routine have the power to transform your entire life, forever!  In this episode you'll hear:  ✏️What biblical scholars say about the difference in our soul and spirit 

GET MY FREE INSTANT POT COOKBOOK: https://www.chefaj.com/instapot-download Disclaimer: This podcast does not provide medical advice. The content of this podcast is provided for informational or educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health issue without consulting your doctor. Always seek medical advice before making any lifestyle changes Dr. Yu IG :https://www.instagram.com/myautoimmunemd/ https://www.facebook.com/MYAutoimmuneMD Website: https://myautoimmunemd.com/ Need more support? See us virtually or in person: https://www.drlifestyle.org/ Dr. Mondala IG: @https://www.instagram.com/drmelissaskitchen/ Website: https://melissamondalamd.com/ Find more recipes here: https://melissamondalamd.com/recipes/ Sign up for her newsletter: https://melissamondalamd.com/contact/ Get FREE masterclass link and join my exclusive courses: https://melissa-mondala.mykajabi.com Learn more through her blogs: https://melissamondalamd.com/blog/

Dr. Christine Cliatt Brown discusses the management of neuropsychiatric symptoms in patients with dementia.       

Despite a prevalence of over 50% among patients with systemic lupus erythematosus (SLE), neuropsychiatric symptoms of SLE (NP-SLE), including anxiety and movement disorders, have not been well understood. The paucity of data examining underlying mechanisms is what spurred the work of Carla M. Cuda, PhD, pointing to microglia as a driver of disease.Dr. Cuda, who is assistant professor of Rheumatology at Northwestern Medicine, and other Northwestern Medicine investigators were the first to show that microglial expression of disease-associated microglia (DAM)-associated genes correlates with the severity of hippocampal- and cerebellar-associated behavioral deficits in an NP-SLE model prior to overt systemic disease. While DAM have been extensively studied in Alzheimer's disease, no studies have specifically examined DAM in NP-SLE, until now.

In today's episode, Dr. Carrie Jones is joined by Dr. Robert Hedaya, a Neuropsychiatrist, Clinical Professor, and Author. They discuss neuropsychiatric symptoms, brain health, brain inflammation, head trauma, and neurodegenerative conditions. Dr. Robert Hedaya is a Clinical Professor of Psychiatry at Georgetown University Medical Center. He is a neuropsychiatrist that teaches functional medicine, psychiatry, brain health, brain inflammation, head trauma, and neurodegenerative conditions, and the founder of The Whole Psychiatry & Brain Recovery Center. Dr. Hedaya also wrote several books, including Understanding Biological Psychiatry, The Anti-depressant Survival Program, and Depression: Advancing the Treatment Paradigm.

Dr. Liang-Kung Chen from the National Yang-Ming Chiao-Tung University, Taipei, Taiwan details a research paper he co-authored that was published by Aging (Aging-US) in Volume 14, Issue 3, entitled, “Predicting neuropsychiatric symptoms of persons with dementia in a day care center using a facial expression recognition system.” DOI - https://doi.org/10.18632/aging.203869 Corresponding author - Liang-Kung Chen - lkchen2@vghtpe.gov.tw Video - https://www.youtube.com/watch?v=wO7PulizlR0 Video transcript - https://aging-us.net/2022/06/28/behind-the-study-facial-expression-recognition-predicts-neuropsychiatric-symptoms-of-dementia/ Abstract Background: Behavioral and psychological symptoms of dementia (BPSD) affect 90% of persons with dementia (PwD), resulting in various adverse outcomes and aggravating care burdens among their caretakers. This study aimed to explore the potential of artificial intelligence-based facial expression recognition systems (FERS) in predicting BPSDs among PwD. Methods: A hybrid of human labeling and a preconstructed deep learning model was used to differentiate basic facial expressions of individuals to predict the results of Neuropsychiatric Inventory (NPI) assessments by stepwise linear regression (LR), random forest (RF) with importance ranking, and ensemble method (EM) of equal importance, while the accuracy was determined by mean absolute error (MAE) and root-mean-square error (RMSE) methods. Results: Twenty-three PwD from an adult day care center were enrolled with ≥ 11,500 FERS data series and 38 comparative NPI scores. The overall accuracy was 86% on facial expression recognition. Negative facial expressions and variance in emotional switches were important features of BPSDs. A strong positive correlation was identified in each model (EM: r = 0.834, LR: r = 0.821, RF: r = 0.798 by the patientwise method; EM: r = 0.891, LR: r = 0.870, RF: r = 0.886 by the MinimPy method), and EM exhibited the lowest MAE and RMSE. Conclusions: FERS successfully predicted the BPSD of PwD by negative emotions and the variance in emotional switches. This finding enables early detection and management of BPSDs, thus improving the quality of dementia care. Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.203869 Keywords - aging, artificial intelligence, behavioral and psychological symptoms of dementia, dementia, facial expression recognition system, machine learning About Aging-US Launched in 2009, Aging-US publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging-US go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways. Please visit our website at http://www.Aging-US.com​​ or connect with us: SoundCloud - https://soundcloud.com/Aging-Us Facebook - https://www.facebook.com/AgingUS/ Twitter - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/agingus​ LinkedIn - https://www.linkedin.com/company/aging/ Pinterest - https://www.pinterest.com/AgingUS/ Aging-US is published by Impact Journals, LLC: http://www.ImpactJournals.com​​ Media Contact 18009220957 MEDIA@IMPACTJOURNALS.COM

Diseases and injuries that damage the brain can impact how we interact with the world and lead to significant and disabling behavioral and psychological symptoms, which are also referred to as neuropsychiatric symptoms. Here to talk about neuropsychiatric symptoms and the challenges they present is Dr. Jeffrey Cummings. Dr. Jeffrey Cummings is the Joy Chambers-Grundy Professor of Brain Science, an endowed professorship at the University of Nevada Las Vegas. He is the Director of the Chambers-Grundy Center for Transformative Neuroscience, a center devoted to using the tools of neuroscience and neurologic drug development to transform people's lives.

My guest this week is Dr. Tom Moorcroft, a board-certified Osteopathic physician who is a global leader in solving complex medical mysteries. Dr. Tom is an expert in the treatment of chronic infectious and autoimmune diseases, including viral illnesses, Lyme disease, Mold illness, and Pediatric Acute Onset Neuropsychiatric Syndrome (often referred to as PANS). He has over 2 decades of experience in the hospital and private practice helping his patients regain their health. Dr. Tom's personal and professional medical philosophy focuses on optimizing the body's self-healing systems in order to achieve optimal health with simple, natural interventions. In this episode, Dr. Tom and I discuss how parents can support neuropsychiatric symptoms caused by chronic infections, autoimmune diseases, and viral illnesses such as Lyme disease and tick-borne illnesses, strep, mold toxicity, PANS/PANDAS, and more. Where to learn more about Dr. Tom Moorcroft ... OriginsOfHealth.com Youtube Instagram Twitter Facebook Coronavirus - Voices of Reason   Connect with Dr. Nicole Beurkens on... Instagram Facebook Drbeurkens.com   Need help with improving your child's behavior naturally?  My book Life Will Get Better is available for purchase, click here to learn more.  Looking for more? Check out my Blog and the Better Behavior Naturally Parent Membership- a resource guide for parents who want to be more effective with improving their child's behavior.  Interested in becoming a patient? Contact us here.

In the UK there are 850,000 people living with dementia, and approximately 90% of people with dementia are affected by neuropsychiatric symptoms at some stage. This term generally refers to things like agitation, hallucinations, delusions, and depression that occur as a result of neurodegenerative disease. Megan O'Hare interviews three researchers who work in and around the field of psychiatry and dementia. Talking specifically about apathy, depression and treatments for the various symptoms. We also delve into the impact of the severe side effects that drug treatments can cause and how safer drugs can be developed. Dr Byron Creese, Senior Research Fellow at University of Exeter covers the range of symptoms and how transcriptomics may hold the key to developing good drugs. Miguel Vasconcelos Da Silva and Isabel Foote discuss their nursing backgrounds and the overlaps and differences between depression and apathy and how a clinical definition for apathy is needed. You can find out more about our panellists, and their work on our website www.dementiaresearcher.nihr.ac.uk. A transcript of this podcast is also available here https://www.dementiaresearcher.nihr.ac.uk/podcast-neuropsychiatric-symptoms-in-dementia Like what you hear? Please review, like, and share our podcast - and don't forget to subscribe to ensure you never miss an episode. Enjoy our content? We are pleased to announce that we are now running a 'midday seminar' series via webinar. The first of these takes place on Monday 30th March - register now at https://ucl.zoom.us/webinar/register/1015852608195/WN_0y29QL8pTSyIIaw2_aUNOg

Please follow along on http://hddrugworks.org/dr-goodmans-blog Dr. LaVonne Goodman's bio: -Family member, lost first husband to HD -Internal Medicine M.D. more than 40 years -Practice limited to HD last decade -Now retired from office practice but serve as a “volunteer physician”, continuing to see homebound and long-term care HD patients -Previous president and board member of the Northwest Chapter of HDSA (now WA State HDSA) -Member of HSG and the combined HSG and EHDN Behavioral Working Group -Co-author of Guides for Treatment of Irritability and Obsessive Compulsive Symptoms in HD (2011) -Co-author of the Guidelines for Management of Neuropsychiatric Symptoms in HD (2018) -Co-author of Contemporary Care of Huntington’s Disease in the Handbook of Clinical Neurology (2018) -Co-founder and writer for Huntington’s Disease Drug Works, a website presently dedicated to HD Care

Please follow along on http://hddrugworks.org/dr-goodmans-blog Dr. LaVonne Goodman's bio: -Family member, lost first husband to HD -Internal Medicine M.D. more than 40 years -Practice limited to HD last decade -Now retired from office practice but serve as a “volunteer physician”, continuing to see homebound and long-term care HD patients -Previous president and board member of the Northwest Chapter of HDSA (now WA State HDSA) -Member of HSG and the combined HSG and EHDN Behavioral Working Group -Co-author of Guides for Treatment of Irritability and Obsessive Compulsive Symptoms in HD (2011) -Co-author of the Guidelines for Management of Neuropsychiatric Symptoms in HD (2018) -Co-author of Contemporary Care of Huntington’s Disease in the Handbook of Clinical Neurology (2018) -Co-founder and writer for Huntington’s Disease Drug Works, a website presently dedicated to HD Care

Dr. LaVonne Goodman's bio: -Family member, lost first husband to HD -Internal Medicine M.D. more than 40 years -Practice limited to HD last decade -Now retired from office practice but serve as a “volunteer physician”, continuing to see homebound and long-term care HD patients -Previous president and board member of the Northwest Chapter of HDSA (now WA State HDSA) -Member of HSG and the combined HSG and EHDN Behavioral Working Group -Co-author of Guides for Treatment of Irritability and Obsessive Compulsive Symptoms in HD (2011) -Co-author of the Guidelines for Management of Neuropsychiatric Symptoms in HD (2018) -Co-author of Contemporary Care of Huntington’s Disease in the Handbook of Clinical Neurology (2018) -Co-founder and writer for Huntington’s Disease Drug Works, a website presently dedicated to HD Care

This week Dr. Connie answers Lupus questions regarding anemia, neuropsychiatric symptoms, and causes of hair loss and dull skin. If you have a question you'd like Dr. Connie to address, post it in the comments and it will be featured in next week's video!

MDS presents the latest research and findings from the field of Movement Disorders. Abstracts of articles from the Society Journal, Movement Disorders, are taken from the June 2015 Issue.

Welcome to the third podcast from EBN. Dr. Dorothy Forbes, associate editor will be taking a closer look at a commentary from the journal with an invited guest. These discussions are designed to help you think about issues raised in the article, as well as the clinical applicability of the original research paper.In this session, Dr Ann Kolanowski, author of the commentary and director, Hartford Centre of Geriatric Nursing Excellence, Pennsylvania State University, will discuss the issues raised in her commentary on a systematic review of community-based non-pharmacological interventions for managing the behavioral and psychological symptoms of dementia. As an expert in the field, Dr. Kolanowski reflects on the systematic review undertaken, and offers insightful comments and ideas that can be used in practice and policy.Dr Kolanowski's commentary http://ebn.bmj.com/content/16/2/67.fullOriginal research article: Henry Brodaty and Caroline Arasaratnam. (2012). Meta-analysis of Non-pharmacological Interventions for Neuropsychiatric Symptoms of Dementia http://1.usa.gov/Toy3il